Earnings Call · Q3 FY2023·2023-11-14

Q3 23EPS +69.11%·Rev n/aQ2 23EPS +54.90%·Rev n/aQ1 23EPS +46.89%·Rev n/aQ4 22EPS +64.82%·Rev n/a⚠ consensus missing

Jaguar Health, Inc. JAGX

Lisa Conte

Carol Lizak — Chief Financial Officer

End of Q&A

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more JAGX calls or request research access.

More JAGX calls Browse calls Request research access